A Feasibility Trial of Eye Movement Desensitization and Reprocessing Therapy- Integrative
Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stres
| Condition(s) | Post Traumatic Stress Symptoms, Quality of Life (QOL), Stress |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Road traffic accidents (RTAs) are a significant public health concern globally, accounting for a substantial proportion of morbidity and mortality. This study evaluates the feasibility and acceptability of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for Ongoing Traumatic Stress (EMDR-IGTP-OTS) in the reduction of posttraumatic stress symptoms, depression, and anxiety, while improving the quality of life in individuals who have experienced traffic accidents. Using a randomized control design, participants aged 18-45 will be assessed at three-time points: pre-treatment, post-treatment, and one-month follow-up. The study employs the DASS-21, UIES-R, and WHOQOL-BREF as evaluation measures. Findings aim to expand evidence on trauma-focused intervention |
| Who can participate | Inclusion Criteria: * Aged between 18 and 45 years. * Experienced a traffic accident 3 months to 10 years prior * Willing to participate and able to understand the intervention components. Exclusion Criteria: * Participants will be excluded from the study if they meet any of the following criteria: * Diagnosed with conditions such as schizophrenia or bipolar disorder, which require specialized treatment beyond the scope of this study. * History of severe head injuries resulting in neurological or cognitive deficits. * Participants who have experienced a traffic accident less than 3 months ago, as immediate post-traumatic responses may not have stabilized |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Lead sponsor | University of the Punjab |
| Locations | Lahore, Punjab Province, Pakistan |
| Start date | 2025-05-01 |
| NCT ID | NCT07027930 |
| Official listing | https://clinicaltrials.gov/study/NCT07027930 |